Menu

Domestication Might Have Sculpted Eyebrow Expressions in Dogs

Dogs have stronger facial muscles compared to wolves, giving them the sad or “puppy dog eyes” look.

Jun 18, 2019
Chia-Yi Hou

ABOVE: © ISTOCK.COM
ANGELABUSERPHOTO

Biologists who compared the facial muscles of dogs and wolves report that dogs have facial muscles that allow them to lift their inner eyebrows, making their eyes appear large or sad. The study suggests that the domestication of dogs by humans has led to this adaptation because humans may view dogs’ eyebrow expressions as an appeal for help, the authors write in PNAS yesterday (June 17). 

The muscles were thinner or weren’t present in the four wolf cadavers they dissected (they also examined six dog heads). In behavioral observations, dogs raised their eyebrows more often and more intensely than wolves did.

Facial muscles in the dog (left) and wolf (right) with the muscles that were different in dogs in red
TIM SMITH

“You don’t typically see such muscle differences in species that are that closely related,” coauthor Anne Burrows of Duquesne University in Pittsburgh tells the Associated Press. The results points to “how important faces can be in capturing our attention, and how powerful facial expression can be in social interaction,” says coauthor Bridget Waller of the University of Portsmouth to BBC News.

“What is so provocative about this finding is the likelihood that our unconscious biases shaped the evolution of the dog’s eye musculature,” Brian Hare of Duke University who edited the study but was not involved with the work tells the Washington Post.

The animals have a history of life experiences that may shape how they behave, Clive Wynne of Arizona State University who was not involved with the study tells the Post. Wynne says he is not completely convinced by this study and would like to see a larger sample of dogs and wolves with varying degrees of past experiences with humans, according to the Post. “A study that describes behavior between dogs or wolves and people has to explain the kinds of life experiences the individuals being tested have undergone.”

The authors plan to continue the research with other dog breeds, coyotes, and domesticated foxes, according to the Post.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.